University of Wisconsin, Madison

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, University of Wisconsin, Madison sits in the top decile of US sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count).

1,039 total trials 151 currently recruiting 712 completed early-phase tilt top decile by trial count

University of Wisconsin, Madison: 1,039 sponsored US clinical trials, 151 recruiting.

University of Wisconsin, Madison sponsors 1,039 registered US clinical trials on ClinicalTrials.gov, 151 of them currently recruiting, and 712 completed. 98 of these trials are in Phase 3-4 (later-stage) and 251 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 10 trials.

Top-decile sponsor footprint

University of Wisconsin, Madison ranks in the top decile of sponsors by registered trial count (#31 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 56/100

712 of 824 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.4%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

1,039 total, page 19 of 21

COMPLETED

Imaging Studies With GE C-Hawk Gamma Camera Compared to Routine Clinical Exam

NCT00256581
COMPLETED

Cardiac Elastography to Determine Strain and Strain Rates in the Heart

NCT00205387
COMPLETED

T Regulatory and Childhood Asthma

NCT00204828
COMPLETED NA

The Effects of Mindfulness Training on Pain Regulation, Negative Affect, Attention, and Social Stress

NCT01301105
COMPLETED NA

Predictor of Advanced Sub-Clinical Atherosclerosis (PASA) Study

NCT00258999
COMPLETED Phase 4

Natrecor for Pulmonary Hypertension in Lung Transplants

NCT00205426
COMPLETED

Posterior Cingulate Function in Persons With Risk Factors for Alzheimer's Disease

NCT00478166
TERMINATED

Effect of Pharmacist Initiated Recommendations On Prescribing For Participants In the Senior MEDS Personalized Medication Review

NCT00205140
COMPLETED Phase 2

Topical Antiperspirant for Hand-Foot Syndrome

NCT00213993
COMPLETED NA

Evaluation of Breast Cancer Surgical Margins Using Optical Spectroscopy

NCT00214292
COMPLETED Phase 2

Phase II Study of VcR-CVAD With Rituximab Consolidation and Maintenance for Untreated Mantle Cell Lymphoma

NCT00581776
COMPLETED Phase 2

Hu14.18-Interleukin-2 Fusion Protein in Treating Patients With Advanced Melanoma

NCT00109863
COMPLETED NA

Heart and Blood Pressure Study: The Effect of Aortic Impedance on Myocardial Relaxation

NCT00204984
COMPLETED Phase 3

Web-based Intervention for Lung Cancer Patients and Their Informal Caregivers

NCT00365963
COMPLETED Phase 2

Intensity Modulated Radiation Therapy (IMRT) Radiotherapy for Treating Prostate Pelvic Nodes

NCT00214136
COMPLETED Phase 1

Prostatic Acid Phosphatase (PAP) Vaccine in Patients With Prostate Cancer

NCT00582140
COMPLETED Phase 2

XELOX for Metastatic Breast Cancer

NCT00204776
COMPLETED NA

Treatment of Hypovitaminosis D in Rheumatoid Arthritis

NCT00423358
COMPLETED Phase 2

Evaluating Simvastatin's Potential Role in Therapy

NCT00486044
COMPLETED NA

Catheterization Laboratory Study: Acute Responses in Diastolic Heart Failure

NCT00204945
COMPLETED

Aging and Cancer Effects (ACE) Study

NCT00204880
TERMINATED Phase 2

Ibritumomab Tiuxetan (Zevalin)+ Rituximab Maintenance

NCT00582166
COMPLETED NA

Beta-2 Polymorphisms and Beta Receptor Selectivity

NCT00214318
COMPLETED

Neuraxial and Neurolytic Analgesia for Intractable Pain

NCT00167726
COMPLETED

Calcium DXA: Impact of Calcium Supplements on Lumbar Spine Bone Mineral Density

NCT00205036
COMPLETED Phase 4

Does Treatment of Hypovitaminosis D Increase Calcium Absorption?

NCT00581828
COMPLETED NA

Correction of Vitamin D Inadequacy in Nursing Home Residents

NCT00204906
COMPLETED

Bone Mineral Density in Pediatric Epilepsy

NCT00204815
COMPLETED Phase 2

A Pilot Study of Campath-1H Induction Therapy Combined With CellCept® Therapy to Allow for a Calcineurin Inhibitor Free Regimen After Renal Transplantation

NCT00214266
COMPLETED Phase 2

Alzheimer's Disease: Potential Benefit of Isoflavones

NCT00205179
COMPLETED

Use of the SNAP II Electroencephalography (EEG) Monitor in Outpatients Undergoing Surgery/Procedures With Sedation

NCT00204711
COMPLETED

Influenza Vaccine in Lung Transplant Patients - Antibody

NCT04533139
COMPLETED Phase 4

Short Course Glucocorticoid Treatment for PTSD

NCT00204737
COMPLETED

Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies Beyond the Season

NCT04530786
COMPLETED

Influenza Vaccine in Lung Transplant Patients - Seroprotection

NCT04531657
COMPLETED

Influenza Vaccine in Lung Transplant Patients - T Cells

NCT04533061
COMPLETED

Influenza Vaccine in Lung Transplant Patients

NCT00205270
COMPLETED NA

Immunological Consequences of Obstructive Sleep Apnea

NCT00214071
COMPLETED NA

The Effects of Mindfulness Training on School Staff

NCT00214357
COMPLETED NA

Instilled Lidocaine vs Placebo for Pain Management During Vacuum Assisted Closure (VAC) Dressing Changes

NCT00585325
TERMINATED Phase 2

Multi-catheter High Dose Rate (HDR) Breast Brachytherapy

NCT00214149
TERMINATED Phase 4

Positron Emission Tomography (PET)-Computed Tomography (CT) in Inflammatory Bowel Disease (IBD)

NCT00205062
COMPLETED

Clinical Outcome Study of the Triad Allograft for Posterior Lumbar Fusion

NCT00205101
COMPLETED Phase 2

Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer

NCT00582634
COMPLETED Phase 4

Smoking Cessation Medications: Efficacy, Mechanisms and Algorithms

NCT00332644
COMPLETED Phase 4

Smoking Cessation Intervention: Effectiveness in Primary Care

NCT00296647
COMPLETED NA

CHESS Caregivers Study: Web-based Support for Informal Caregivers in Cancer

NCT00214162
COMPLETED

Impact of Moderate Alcohol Use on Hepatitis C Virus (HCV) Progression

NCT00205075
COMPLETED

Influenza Vaccine in Lung Transplant Patients - Persistence of Antibodies

NCT04531787
COMPLETED Phase 2

Effects of CLA Supplements on Body Weight and Fat Oxidation

NCT00204932
← Previous Page 19 of 21 Next →

Phase Distribution

PhaseTrial count
Phase 1 109
Phase 2 142
Phase 3 19
Phase 4 79

Therapeutic Areas

Healthy 10
Obesity 10
Prostate Cancer 9
Breast Cancer 8
Pain 7
Magnetic Resonance Imaging 6
Surgery 6
Smoking Cessation 6
Smoking 5
Anxiety 5

What is open in the University of Wisconsin, Madison pipeline

151 recruiting of 1,039 indexed (15% open); 712 completed (69%).

Phase mix: 98 late (III/IV) vs 251 early (I/II) (early-phase heavy).

Top condition: Healthy (10 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

University of Wisconsin, Madison: open-pipeline peers nationwide

Peers matched on 1,039 registered trials and 15% open enrollment, not the therapeutic-area sidebar.

University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 05001,0001,500 6%8%10%12%14%16% Total trials Recruiting share University of Wisconsin, MadisonUniversity of WashingtonBristol-Myers SquibbUniversity of FloridaUniversity of North Carolina, Chapel HillMasonic Cancer Center, University of MinnesotaModernaTXUnited States Naval Medical Center, San DiegoThe Cleveland Clinic
University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

University of Wisconsin, Madison sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 1,039 trials (± recruiting share)

Sponsors near 15% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this University of Wisconsin, Madison page

1,039 registered trials is a research-attention snapshot, not an endorsement of University of Wisconsin, Madison or any single study.

  • 151 of University of Wisconsin, Madison's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Healthy is the condition University of Wisconsin, Madison studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Wisconsin, Madison pipeline card: 1,039 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.